|
1
|
Wallis LI, Paley MN, Graham JM, Grünewald
RA, Wignall EL, Joy HM and Griffiths PD: MRI assessment of basal
ganglia iron deposition in Parkinson's disease. J Magn Reson
Imaging. 28:1061–1067. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
House MJ, St Pierre TG, Foster JK, Martins
RN and Clarnette R: Quantitative MR imaging R2 relaxometry in
elderly participants reporting memory loss. AJNR Am J Neuroradiol.
27:430–439. 2006.PubMed/NCBI
|
|
3
|
Connor JR, Menzies SL, St Martin SM and
Mufson EJ: A histochemical study of iron, transferrin, and ferritin
in Alzheimer's diseased brains. J Neurosci Res. 31:75–83. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zecca L, Youdim MB, Riederer P, Connor JR
and Crichton RR: Iron, brain ageing and neurodegenerative
disorders. Nat Rev Neurosci. 5:863–873. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
van Duijn S, Bulk M, van Duinen SG,
Nabuurs RJA, van Buchem MA, van der Weerd L and Natté R: Cortical
Iron Reflects Severity of Alzheimer's Disease. J Alzheimers Dis.
60:1533–1545. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mairuae N, Connor JR and Cheepsunthorn P:
Increased cellular iron levels affect matrix metalloproteinase
expression and phagocytosis in activated microglia. Neurosci Lett.
500:36–40. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kanai H, Sawa A, Chen RW, Leeds P and
Chuang DM: Valproic acid inhibits histone deacetylase activity and
suppresses excitotoxicity-induced GAPDH nuclear accumulation and
apoptotic death in neurons. Pharmacogenomics J. 4:336–344. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li R and El-Mallahk RS: A novel evidence
of different mechanisms of lithium and valproate neuroprotective
action on human SY5Y neuroblastoma cells: Caspase-3 dependency.
Neurosci Lett. 294:147–150. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mora A, Gonzalez Polo RA, Fuentes JM,
Soler G and Centeno F: Different mechanisms of protection against
apoptosis by valproate and Li+. Eur J Biochem. 266:886–891. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ximenes JC, Neves KR, Leal LK, do Carmo
MR, Brito GA, Naffah-Mazzacoratti MG, Cavalheiro ÉA and Viana GS:
Valproic Acid Neuroprotection in the 6-OHDA Model of Parkinson's
Disease Is Possibly Related to Its Anti-Inflammatory and HDAC
Inhibitory Properties. J Neurodegener Dis.
2015:3137022015.PubMed/NCBI
|
|
11
|
Xuan AG, Pan XB, Wei P, Ji WD, Zhang WJ,
Liu JH, Hong LP, Chen WL and Long DH: Valproic acid alleviates
memory deficits and attenuates amyloid-β deposition in transgenic
mouse model of Alzheimer's disease. Mol Neurobiol. 51:300–312.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Suh HS, Choi S, Khattar P, Choi N and Lee
SC: Histone deacetylase inhibitors suppress the expression of
inflammatory and innate immune response genes in human microglia
and astrocytes. Journal of neuroimmune pharmacology: the official
journal of the Society on NeuroImmune Pharmacology. 5:521–532.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lauterbach EC: Repurposing psychiatric
medicines to target activated microglia in anxious mild cognitive
impairment and early Parkinson's disease. Am J Neurodegener Dis.
5:29–51. 2016.PubMed/NCBI
|
|
14
|
Smith AM, Gibbons HM and Dragunow M:
Valproic acid enhances microglial phagocytosis of
amyloid-beta(1–42). Neuroscience. 169:505–515. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brown GC and Vilalta A: How microglia kill
neurons. Brain Res. 1628(Pt B): 1–297. 2015.PubMed/NCBI
|
|
16
|
Brown GC: Nitric oxide and neuronal death.
Nitric Oxide. 23:153–165. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brown GC and Bal-Price A: Inflammatory
neurodegeneration mediated by nitric oxide, glutamate, and
mitochondria. Mol Neurobiol. 27:325–355. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thornton P, Pinteaux E, Gibson RM, Allan
SM and Rothwell NJ: Interleukin-1-induced neurotoxicity is mediated
by glia and requires caspase activation and free radical release. J
Neurochem. 98:258–266. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ye L, Huang Y, Zhao L, Li Y, Sun L, Zhou
Y, Qian G and Zheng JC: IL-1β and TNF-α induce neurotoxicity
through glutamate production: A potential role for neuronal
glutaminase. J Neurochem. 125:897–908. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tak PP and Firestein GS: NF-kappaB: A key
role in inflammatory diseases. J Clin Invest. 107:7–11. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Breuer W, Epsztejn S and Cabantchik ZI:
Iron acquired from transferrin by K562 cells is delivered into a
cytoplasmic pool of chelatable iron(II). J Biol Chem.
270:24209–24215. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mairuae N, Connor JR, Lee SY,
Cheepsunthorn P and Tongjaroenbuangam W: The effects of okra
(Abelmoschus esculentus Linn.) on the cellular events associated
with Alzheimer's disease in a stably expressed HFE neuroblastoma
SH-SY5Y cell line. Neurosci Lett. 603:6–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tenopoulou M, Kurz T, Doulias PT, Galaris
D and Brunk UT: Does the calcein-AM method assay the total cellular
‘labile iron pool’ or only a fraction of it? Biochem J.
403:261–266. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Epsztejn S, Kakhlon O, Glickstein H,
Breuer W and Cabantchik I: Fluorescence analysis of the labile iron
pool of mammalian cells. Anal Biochem. 248:31–40. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stäubli A and Boelsterli UA: The labile
iron pool in hepatocytes: Prooxidant-induced increase in free iron
precedes oxidative cell injury. Am J Physiol. 274:G1031–G1037.
1998.PubMed/NCBI
|
|
26
|
Lipiński P, Drapier JC, Oliveira L,
Retmańska H, Sochanowicz B and Kruszewski M: Intracellular iron
status as a hallmark of mammalian cell susceptibility to oxidative
stress: A study of L5178Y mouse lymphoma cell lines differentially
sensitive to H(2)O(2). Blood. 95:2960–2966. 2000.PubMed/NCBI
|
|
27
|
Lovell MA, Robertson JD, Teesdale WJ,
Campbell JL and Markesbery WR: Copper, iron and zinc in Alzheimer's
disease senile plaques. J Neurol Sci. 158:47–52. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bharti AC, Donato N, Singh S and Aggarwal
BB: Curcumin (diferuloylmethane) down-regulates the constitutive
activation of nuclear factor-kappa B and IkappaBalpha kinase in
human multiple myeloma cells, leading to suppression of
proliferation and induction of apoptosis. Blood. 101:1053–1062.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Park MH and Hong JT: Roles of NF-κB in
Cancer and Inflammatory Diseases and Their Therapeutic Approaches.
Cells. 5:52016. View Article : Google Scholar
|
|
30
|
Beg AA, Finco TS, Nantermet PV and Baldwin
AS Jr: Tumor necrosis factor and interleukin-1 lead to
phosphorylation and loss of I kappa B alpha: A mechanism for
NF-kappa B activation. Mol Cell Biol. 13:3301–3310. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Palombella VJ, Rando OJ, Goldberg AL and
Maniatis T: The ubiquitin-proteasome pathway is required for
processing the NF-kappa B1 precursor protein and the activation of
NF-kappa B. Cell. 78:773–785. 1994. View Article : Google Scholar : PubMed/NCBI
|
